Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT05000294
Brief Title:
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Official Title:
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Study:
NCT05000294
Protocol Section:
NCT05000294